JOHNSON & JOHNSON - 16 Feb 2024 Form 4 Insider Report for CVRx, Inc. (CVRX)

Reporting relationship: 10%+ Owner
Issuer ticker: CVRX
Reported as of: 16 Feb 2024
Net transaction value: +$2,671
SEC form: 4
Accepted by SEC: 06 Mar 2024, 15:42:31 UTC
Prior SEC filing: 25 Aug 2023
Next SEC filing: 10 Apr 2024
Source filing: View source filing
Reporting owner signature: Johnson & Johnson By: /s/ Marc Larkins, Secretary

Key filing fact

JOHNSON & JOHNSON filed Form 4 for CVRx, Inc. (CVRX) on 06 Mar 2024.

Key facts

This page summarizes JOHNSON & JOHNSON's Form 4 filing for CVRx, Inc. (CVRX).
33 reported transactions and 16 derivative rows are listed below.
Accepted by SEC: 06 Mar 2024, 15:42.

Change

Previous filing in this sequence was filed on 25 Aug 2023.
Current net transaction value: +$2,671.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CVRX transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value: $96,021
Shares: +607,725
Change %: +17%
Price: $0.1580^*
Shares after: 4,103,300
Date: 16 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Footnotes: F1

CVRX transaction

Common Stock

Sale

Transaction value: $96,142
Shares: -3,725
Change %: -0.09%
Price: $25.81
Shares after: 4,099,575
Date: 16 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Footnotes: F1, F2

CVRX transaction

Common Stock

Options Exercise

Transaction value: $37.45
Shares: +158
Change %: +0%
Price: $0.2370^*
Shares after: 4,099,733
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Footnotes: F1

CVRX transaction

Common Stock

Options Exercise

Transaction value: $44.79
Shares: +189
Change %: +0%
Price: $0.2370^*
Shares after: 4,099,922
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Footnotes: F1

CVRX transaction

Common Stock

Options Exercise

Transaction value: $39.1
Shares: +165
Change %: +0%
Price: $0.2370^*
Shares after: 4,100,087
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Footnotes: F1

CVRX transaction

Common Stock

Options Exercise

Transaction value: $27.97
Shares: +118
Change %: +0%
Price: $0.2370^*
Shares after: 4,100,205
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Footnotes: F1

CVRX transaction

Common Stock

Options Exercise

Transaction value: $16.83
Shares: +71
Change %: +0%
Price: $0.2370^*
Shares after: 4,100,276
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Footnotes: F1

CVRX transaction

Common Stock

Options Exercise

Transaction value: $5.45
Shares: +23
Change %: +0%
Price: $0.2370^*
Shares after: 4,100,299
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Footnotes: F1

CVRX transaction

Common Stock

Options Exercise

Transaction value: $20.14
Shares: +85
Change %: +0%
Price: $0.2370^*
Shares after: 4,100,384
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Footnotes: F1

CVRX transaction

Common Stock

Options Exercise

Transaction value: $180
Shares: +758
Change %: +0.02%
Price: $0.2370^*
Shares after: 4,101,142
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Footnotes: F1

CVRX transaction

Common Stock

Options Exercise

Transaction value: $116
Shares: +489
Change %: +0.01%
Price: $0.2370^*
Shares after: 4,101,631
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Footnotes: F1

CVRX transaction

Common Stock

Options Exercise

Transaction value: $138
Shares: +584
Change %: +0.01%
Price: $0.2370^*
Shares after: 4,102,215
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Footnotes: F1

CVRX transaction

Common Stock

Options Exercise

Transaction value: $71.1
Shares: +300
Change %: +0.01%
Price: $0.2370^*
Shares after: 4,102,515
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Footnotes: F1

CVRX transaction

Common Stock

Options Exercise

Transaction value: $524
Shares: +442
Change %: +0.01%
Price: $1.19
Shares after: 4,102,957
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Footnotes: F1

CVRX transaction

Common Stock

Options Exercise

Transaction value: $168
Shares: +142
Change %: +0%
Price: $1.19
Shares after: 4,103,099
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Footnotes: F1

CVRX transaction

Common Stock

Options Exercise

Transaction value: $997
Shares: +252
Change %: +0.01%
Price: $3.96
Shares after: 4,103,351
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Footnotes: F1

CVRX transaction

Common Stock

Options Exercise

Transaction value: $406
Shares: +79
Change %: +0%
Price: $5.14
Shares after: 4,103,430
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CVRX transaction Derivative

Warrant to Purchase Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value: $0
Shares: -607,225
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 16 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Underlying class: Common Stock
Underlying amount: 607,225
Exercise price: $0.1580
Footnotes: F1, F3, F4

CVRX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -158
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc
Underlying class: Common Stock
Underlying amount: 158
Exercise price: $0.2370
Footnotes: F1, F5

CVRX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -189
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Underlying class: Common Stock
Underlying amount: 189
Exercise price: $0.2370
Footnotes: F1, F5

CVRX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -165
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Underlying class: Common Stock
Underlying amount: 165
Exercise price: $0.2370
Footnotes: F1, F5

CVRX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -118
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc
Underlying class: Common Stock
Underlying amount: 118
Exercise price: $0.2370
Footnotes: F1, F5

CVRX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -71
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Underlying class: Common Stock
Underlying amount: 71
Exercise price: $0.2370
Footnotes: F1, F5

CVRX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -23
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Underlying class: Common Stock
Underlying amount: 23
Exercise price: $0.2370
Footnotes: F1, F5

CVRX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -85
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Underlying class: Common Stock
Underlying amount: 85
Exercise price: $0.2370
Footnotes: F1, F5

CVRX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -758
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Underlying class: Common Stock
Underlying amount: 758
Exercise price: $0.2370
Footnotes: F1, F5

CVRX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -489
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Underlying class: Common Stock
Underlying amount: 489
Exercise price: $0.2370
Footnotes: F1, F5

CVRX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -584
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Underlying class: Common Stock
Underlying amount: 584
Exercise price: $0.2370
Footnotes: F1, F5, F6

CVRX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -300
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Underlying class: Common Stock
Underlying amount: 300
Exercise price: $0.2370
Footnotes: F1, F5

CVRX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -442
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Underlying class: Common Stock
Underlying amount: 442
Exercise price: $1.19
Footnotes: F1, F5, F7

CVRX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -142
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc
Underlying class: Common Stock
Underlying amount: 142
Exercise price: $1.19
Footnotes: F1, F5

CVRX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -252
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Underlying class: Common Stock
Underlying amount: 252
Exercise price: $3.96
Footnotes: F1, F5, F8

CVRX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -79
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 29 Feb 2024
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Underlying class: Common Stock
Underlying amount: 79
Exercise price: $5.14
Footnotes: F1, F5, F9

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. ("JJDC"), a wholly-owned subsidiary of Johnson & Johnson.

Footnote F2

On February 16, 2024, JJDC exercised the Warrant to purchase 607,725 shares of Common Stock and paid the exercise price (adjusted per the net exercise terms of the Warrant) on a cashless basis, resulting in the withholding of 3,725 of the Warrant shares to pay the exercise price and issuance to JJDC of the remaining 604,000 shares.

Footnote F3

The Warrant became exercisable for Common Stock upon the closing of the Issuer's initial public offering and was to expire on the earlier of (i) an acquisition or asset transfer involving the Issuer or (ii) 180 days after receipt of the data from the post-market stage of the Issuer's BeAT-HF pivotal trial.

Footnote F4

The Warrant was transferred to JJDC from Biosense Webster, Inc., also a wholly-owned subsidiary of Johnson & Johnson, on February 14, 2024.

Footnote F5

Fully vested.

Footnote F6

174 options previously reported as issued and held by JJDC were previously canceled by the Issuer for no value.

Footnote F7

316 options previously reported as issued and held by JJDC were previously canceled by the Issuer for no value.

Footnote F8

506 options previously reported as issued and held by JJDC were previously canceled by the Issuer for no value.

Footnote F9

1,185 options previously reported as issued and held by JJDC were previously canceled by the Issuer for no value.